Coronavirus disease (COVID-19) was discovered in December 2019. Kenya reported its first case on the 13th of March 2020
Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, the infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.
Standard recommendations to prevent infection spread include physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning your hands, and coughing into a bent elbow or tissue.
Clinical Videos for Healthcare Providers
This was a comprehensive review of the published and grey literature on the ability of hospitals in Kenya to provide emergency and critical care services and to identify priority actions for use by policymakers and other stakeholders as a roadmap toward strengthening the COVID-19 response in the country.
This living guideline responds to emerging evidence from randomised controlled trials (RCTs) on existing and new drug treatments for covid-19. Among these are large national and international platform trials (such as RECOVERY, WHO SOLIDARITY, and DISCOVERY).
Patients who are assessed by a Health Care Worker and meet all the criteria below will be considered for home-based isolation and care; laboratory-confirmed COVID-19, asymptomatic patients or patients with mild symptoms of COVID-19, absence of comorbidities, and access to a suitable space for home-based isolation and care.
As the COVID‐19 pandemic continues to unfold here in Kenya, more and more patients are requiring oxygen. To increase the capacity of healthcare facilities to provide oxygen to more patients, we have installed Oxygen Gas Manifolds in the emergency departments at the county referral hospitals in Machakos, Kiambu (COVID-19 isolation centre) and Kajiado counties and at the Alupe Sub-County Hospital COVID-19 isolation centre in Busia county. These are the hardest hit counties at the moment and we continue to seek additional support to support more facilities.
The findings of this well done randomized controlled trial indicate that in patients with COVID-19 pneumonia, that dexamethasone improves 28d mortality compared to placebo in patients requiring invasive mechanical ventilation (IMV) (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29).
This document provides general guidance for Emergency Medical Service (EMS) preparedness and response to COVID19. At a local and state level, regulations and resource configurations may vary. In addition to these recommendations, EMS agencies should consult with local stakeholders.